Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) EBT: 2016-2025

Historic EBT for Assembly Biosciences (ASMB) over the last 9 years, with Sep 2025 value amounting to -$9.2 million.

  • Assembly Biosciences' EBT rose 4.34% to -$9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.2 million, marking a year-over-year increase of 3.75%. This contributed to the annual value of -$39.8 million for FY2024, which is 34.89% up from last year.
  • Latest data reveals that Assembly Biosciences reported EBT of -$9.2 million as of Q3 2025, which was down 4.29% from -$8.8 million recorded in Q2 2025.
  • Over the past 5 years, Assembly Biosciences' EBT peaked at -$8.8 million during Q1 2025, and registered a low of -$62.8 million during Q4 2021.
  • In the last 3 years, Assembly Biosciences' EBT had a median value of -$9.6 million in 2024 and averaged -$11.7 million.
  • In the last 5 years, Assembly Biosciences' EBT tumbled by 461.45% in 2021 and then skyrocketed by 52.10% in 2024.
  • Over the past 4 years, Assembly Biosciences' EBT (Quarterly) stood at -$62.8 million in 2021, then reached -$10.9 million in 2023, then grew by 4.74% to -$10.4 million in 2024, then increased by 4.34% to -$9.2 million in 2025.
  • Its EBT was -$9.2 million in Q3 2025, compared to -$8.8 million in Q2 2025 and -$8.8 million in Q1 2025.